2026 Andras Perl: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	75	5194	4796	2469	2222	235	35783

Overview

Andras Perl is affiliated with SUNY Upstate Medical University in the United States. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with a substantial body of work spanning these disciplines.

The primary subfields of study in their research include:

Immunology
Rheumatology
Molecular Biology
Pathology and Forensic Medicine
Genetics

Andras Perl's research covers a variety of main topics, notably:

Systemic Lupus Erythematosus Research
PI3K/AKT/mTOR signaling in cancer
Immune Cell Function and Interaction
T-cell and B-cell Immunology
Neonatal Health and Biochemistry
Monoclonal and Polyclonal Antibodies Research
Innovations in Medical Education

The scientist's recent publications include:

Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine, 2020, Clinical Immunology
Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation, 2024, Nature Communications
Metabolic Targets for Treatment of Autoimmune Diseases, 2020, Immunometabolism
Renal mTORC1 activation is associated with disease activity and prognosis in lupus nephritis, 2022, Lara D. Veeken
Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis, 2023, Nature Metabolism

Frequent co-authors in Andras Perl's work include:

Akshay Patel
Katalin Bánki
Dániel Krakkó
Thomas Winans
Zachary Oaks

Publication venues where Andras Perl has frequently published are:

Clinical Immunology
ACR Open Rheumatology
Frontiers in Immunology
Autoimmunity Reviews
Nature Communications

In addition to articles, Andras Perl has authored a book published by Frontiers Media titled New Biomarkers for the Diagnosis and Treatment of Systemic Lupus Erythematosus (2022).

Best Publications

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif

10661
Citations
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

8488
Citations
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

895
Citations
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus.

Peter Gergely;Craig Grossman;Brian Niland;Ferenc Puskas

475
Citations
N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial

Zhi-Wei Lai;Robert Hanczko;Eduardo Bonilla;Tiffany N. Caza

474
Citations
Rapamycin reduces disease activity and normalizes T cell activation–induced calcium fluxing in patients with systemic lupus erythematosus

David Fernandez;Eduardo Bonilla;Naureen Mirza;Brian Niland

424
Citations
Oxidative stress in the pathology and treatment of systemic lupus erythematosus.

Andras Perl

397
Citations
Elevation of Mitochondrial Transmembrane Potential and Reactive Oxygen Intermediate Levels Are Early Events and Occur Independently from Activation of Caspases in Fas Signaling

Katalin Banki;Eliza Hutter;Nick J. Gonchoroff;Andras Perl

392
Citations
Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial

Zhi-Wei Lai;Ryan Kelly;Thomas Winans;Ivan Marchena

346
Citations
Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases

Andras Perl

345
Citations
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

287
Citations
Glutathione Levels and Sensitivity to Apoptosis Are Regulated by Changes in Transaldolase Expression

Katalin Banki;Eliza Hutter;Emanuela Colombo;Nick J. Gonchoroff

276
Citations
Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity.

Andras Perl;Peter Gergely;Gyorgy Nagy;Agnes Koncz

272
Citations
Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation.

David R. Fernandez;Tiffany Telarico;Eduardo Bonilla;Qing Li

259
Citations
mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging

Andras Perl

252
Citations
Persistent Mitochondrial Hyperpolarization, Increased Reactive Oxygen Intermediate Production, and Cytoplasmic Alkalinization Characterize Altered IL-10 Signaling in Patients with Systemic Lupus Erythematosus

Peter Gergely;Brian Niland;Nick Gonchoroff;Rudolf Pullmann

250
Citations
Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I gag-reactive autoantibodies.

K Banki;J Maceda;E Hurley;E Ablonczy

223
Citations
Endogenous retroviruses : potential etiologic agents in autoimmunity

Arthur M. Krieg;Mark F. Gourley;Andras Perl

209
Citations
T Cell Activation-Induced Mitochondrial Hyperpolarization Is Mediated by Ca2+- and Redox-Dependent Production of Nitric Oxide

Gyorgy Nagy;Agnes Koncz;Andras Perl

207
Citations
Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and sysemic lupus erythematosus

György Nagy;Agnes Koncz;Tiffany Telarico;David Fernandez

207
Citations